These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1815428)

  • 1. Procainamide-induced pseudo-obstruction in a diabetic patient.
    Peterson AM; Conrad SD; Bell JM
    DICP; 1991 Dec; 25(12):1334-5. PubMed ID: 1815428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia following sustained-release procainamide.
    Meisner DJ; Carlson RJ; Gottlieb AJ
    Arch Intern Med; 1985 Apr; 145(4):700-2. PubMed ID: 2580499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pure red cell aplasia associated with administration of sustained-release procainamide.
    Giannone L; Kugler JW; Krantz SB
    Arch Intern Med; 1987 Jun; 147(6):1179-80. PubMed ID: 3036033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe neutropenia due to sustained-release procainamide.
    Hoyt RE
    South Med J; 1987 Sep; 80(9):1196-7. PubMed ID: 3629327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
    Kalin ML; Babich MF; Klinke WP; Hui WK
    Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged thrombocytopenia associated with procainamide in an elderly patient.
    Landrum EM; Siegert EA; Hanlon JT; Currie MS
    Ann Pharmacother; 1994 Oct; 28(10):1172-6. PubMed ID: 7841573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained-release procainamide-induced reversible granulocytopenia after myocardial infarction.
    Abe H; Suzuka H; Tasaki H; Kuroiwa A
    Jpn Heart J; 1995 Jul; 36(4):483-7. PubMed ID: 7474364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
    Anderson JL
    Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agranulocytosis due to new sustained-release procainamide.
    Berger BE; Hauser DJ
    Am Heart J; 1983 Jun; 105(6):1035-6. PubMed ID: 6858823
    [No Abstract]   [Full Text] [Related]  

  • 10. Severe neutropenia associated with procainamide: comparison of sustained release and conventional preparations.
    Meyers DG; Gonzalez ER; Peters LL; Davis RB; Feagler JR; Egan JD; Nair CK
    Am Heart J; 1985 Jun; 109(6):1393-5. PubMed ID: 4003250
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe neutropenia associated with sustained-release procainamide.
    Ellrodt AG; Murata GH; Riedinger MS; Stewart ME; Mochizuki C; Gray R
    Ann Intern Med; 1984 Feb; 100(2):197-201. PubMed ID: 6691661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intestinal pseudo-obstruction caused by diltiazem in a neutropenic patient.
    Young RP; Wu H
    Ann Pharmacother; 2005 Oct; 39(10):1749-51. PubMed ID: 16144882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption kinetics of procainamide in humans.
    Manion CV; Lalka D; Baer DT; Meyer MB
    J Pharm Sci; 1977 Jul; 66(7):981-4. PubMed ID: 886461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible case of procainamide-induced intrahepatic cholestatic jaundice.
    Chuang LC; Tunier AP; Akhtar N; Levine SM
    Ann Pharmacother; 1993 Apr; 27(4):434-7. PubMed ID: 8477118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pharmacokinetic comparison of two sustained-release oral procainamide preparations.
    Hore P; Bones P; Rollinson T; Ikram H
    Br J Clin Pharmacol; 1979 Sep; 8(3):267-71. PubMed ID: 497093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fludarabine induced intestinal pseudo-obstruction: case report and literature review.
    Campbell S; Thomas R; Parker A; Ghosh S
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):711-3. PubMed ID: 10912495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant polycystic kidney disease showing rupture of a lateral ventral hernia following paralytic ileus.
    Kato T; Ubara Y; Tagami T; Sawa N; Hoshino J; Suwabe T; Yamagata T; Katori H; Takemoto F; Hara S; Matoba S; Takaichi K
    Intern Med; 2005 Apr; 44(4):311-4. PubMed ID: 15897642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procainamide-induced myasthenic crisis.
    Godley PJ; Morton TA; Karboski JA; Tami JA
    Ther Drug Monit; 1990 Jul; 12(4):411-4. PubMed ID: 2396315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procainamide-induced agranulocytosis.
    Reidy TJ; Upshaw JD
    South Med J; 1984 Dec; 77(12):1582-4. PubMed ID: 6505768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective use of magnesium for acquired torsade de pointes in a 4-month-old infant.
    Bell D; Thoele DG; Mander G; Bauman JL
    Pediatr Cardiol; 1995; 16(2):79-81. PubMed ID: 7784240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.